Rituximab in the treatment of immune-mediated thrombotic thrombocytopenic purpura.

ABSTRACT:

SUBMITTER: Ozpolat HT 

PROVIDER: S-EPMC10497387 | biostudies-literature | 2023 Sep

REPOSITORIES: biostudies-literature